Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.16M Sell
2,423
-2,019
-45% -$1.03M 0.03% 456
2025
Q4
$2.5M Buy
4,442
+1,771
+66% +$1.01M 0.07% 282
2025
Q3
$1.37M Sell
2,671
-1,528
-36% -$667K 0.04% 388
2025
Q2
$1.32M Hold
4,199
0.04% 416
2025
Q1
$1.28M Sell
4,199
-308
-7% -$104K 0.04% 380
2024
Q4
$1.5M Sell
4,507
-645
-13% -$219K 0.05% 346
2024
Q3
$1.72M Buy
5,152
+508
+11% +$193K 0.05% 324
2024
Q2
$1.91M Buy
4,644
+283
+6% +$112K 0.06% 282
2024
Q1
$1.76M Sell
4,361
-1,374
-24% -$483K 0.06% 308
2023
Q4
$1.76M Buy
5,735
+121
+2% +$32.7K 0.06% 316
2023
Q3
$1.36M Buy
5,614
+1,647
+42% +$421K 0.05% 347
2023
Q2
$953K Buy
3,967
+2,424
+157% +$504K 0.03% 436
2023
Q1
$290K Hold
1,543
0.01% 775
2022
Q4
$328K Buy
+1,543
New +$308K 0.01% 770
2022
Q3
Sell
-852
Closed -$128K 1398
2022
Q2
$128K Hold
852
﹤0.01% 1008
2022
Q1
$139K Buy
852
+296
+53% +$48.8K ﹤0.01% 1019
2021
Q4
$121K Sell
556
-63
-10% -$13.2K ﹤0.01% 989
2021
Q3
$117K Hold
619
﹤0.01% 977
2021
Q2
$109K Hold
619
﹤0.01% 1018
2021
Q1
$102K Hold
619
﹤0.01% 931
2020
Q4
$86K Hold
619
﹤0.01% 870
2020
Q3
$69K Hold
619
﹤0.01% 814
2020
Q2
$58K Buy
+619
New +$52.7K ﹤0.01% 760

Other funds holding MEDP

Vestcor Inc's MEDP Position: Q1 2026 in Review

Vestcor Inc reduced its Medpace (MEDP) stake by 45% in Q1 2026, selling an estimated $1.03M and leaving 2,423 shares worth $1.16M. The position accounts for 0.03% of the portfolio, ranked #456.

Vestcor Inc first reported a position in MEDP in Q2 2020 and has held it in 23 quarters since. The position peaked at $2.5M in Q4 2025. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • Vestcor Inc held 2,423 shares of Medpace worth $1.16M as of Q1 2026.
  • Vestcor Inc sold 2,019 Medpace shares in Q1 2026, an estimated $1.03M.
  • Medpace made up 0.03% of Vestcor Inc's portfolio in Q1 2026, its #456 holding.
  • Vestcor Inc first reported a position in Medpace in Q2 2020 and has held it in 23 quarters since.
  • Vestcor Inc's Medpace position peaked at $2.5M in Q4 2025.
  • 729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Vestcor Inc's 13F filing for Q1 2026, filed 12 May 2026.